Wiesława Niklińska
Niklińska, Wiesława
VIAF ID: 52152682489223310202 ( Personal )
Permalink: http://viaf.org/viaf/52152682489223310202
Preferred Forms
-
100 1 _ ‡a Niklińska, Wiesława
-
100 0 _
‡a
Wiesława Niklińska
4xx's: Alternate Name Forms (11)
Works
| Title | Sources |
|---|---|
| Bone as a source of organism vitality and regeneration |
|
| Chronic high-protein diet induces oxidative stress and alters the salivary gland function in rats. |
|
| Circulating free DNA and p53 antibodies in plasma of patients with ovarian epithelial cancers |
|
| Clinical Implications of Hepatocyte Growth Factor, Interleukin-20, and Interleukin-22 in Serum and Bronchoalveolar Fluid of Patients with Non-Small Cell Lung Cancer. |
|
| Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer. |
|
| Core-shell magnetic nanoparticles display synergistic antibacterial effects against Pseudomonas aeruginosa and Staphylococcus aureus when combined with cathelicidin LL-37 or selected ceragenins. |
|
| Detection of DNA methylation in eucaryotic cells |
|
| DNA methylation in states of cell physiology and pathology |
|
| Effect of endurance training on the phospholipid content of skeletal muscles in the rat |
|
| The epidemiology of asbestos-related diseases. |
|
| Fetal membranes as a source of stem cells |
|
| Gene Expression Signature Differentiates Histology But Not Progression Status of Early-Stage NSCLC. |
|
| Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer |
|
| Immunohistochemical markers of cancerogenesis in the lung |
|
| The impact of immune responses on lung cancer and the development of new treatment modalities. |
|
| Interleukin-33 as a New Marker of Pulmonary Sarcoidosis. |
|
| Intratumoral lymphatic vessel density, and intratumoral and peritumoral lymphatic vessel invasion as predictive factors of lymph node metastasis and prognostic factors in esophageal cancer |
|
| Lymphatics-associated genes are downregulated at transcription level in non-small cell lung cancer. |
|
| Lysosomal Exoglycosidase Profile and Secretory Function in the Salivary Glands of Rats with Streptozotocin-Induced Diabetes. |
|
| Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications. |
|
| Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma. |
|
| New monoallelic combination of KRAS gene mutations in codons 12 and 13 in the lung adenocarcinoma |
|
| Osteoprotegerin/sRANKL Signaling System in Pulmonary Sarcoidosis: A Bronchoalveolar Lavage Study |
|
| Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer |
|
| Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC). |
|
| Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer |
|
| Prognostic value of vascular endothelial growth factor-C and podoplanin mRNA expression in esophageal cancer |
|
| Report from the first meeting of the 'European Network on Translational Research in Lung Cancer Amsterdam-Barcelona-Bialystok-Heidelberg'. Thoraxklinik Heidelberg, Germany, July 25, 2001 |
|
| Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus |
|
| Tumor necrosis factor-alpha and its receptors in epithelial ovarian cancer |
|
| Types and localisation of p53 gene mutations: a report on 332 non-small cell lung cancer patients |
|
| Validation for histology-driven diagnosis in non-small cell lung cancer using hsa-miR-205 and hsa-miR-21 expression by two different normalization strategies. |
|
